Clinical Trial Insurance. Prior to TSD initiating any clinical trial with respect to a Compound or Product, TSD shall have and maintain such type and amounts of liability insurance covering the development activities contemplated hereunder and that are normal and customary in the pharmaceutical industry generally for parties similarly situated, and shall name PPD as an additional insured thereunder. TSD shall furnish to PPD certificates evidencing the insurance coverage, including amendments and revisions thereto, within five (5) business days of PPD’s written request.
Clinical Trial Insurance. Sponsor has effected sufficient insurance to compensate damages in the event of the death of the Trial Participant or in the event of an injury to the health of Trial Participants as a direct result of their 10.3
Clinical Trial Insurance. Sponsor has effected sufficient insurance to compensate damages in the event of the death of the Trial Participant or in the event of an injury to the health of Trial Participants as a direct result of their participation in the Trial in accordance with the provisions of Section 52 (3) f) of Act No. 378/2007 Coll. The insurance covers also the treatment in case of an injury. To that extent, such clinical trial insurance may also cover the relevant liability of Provider or Investigator. However, the Parties understand that the clinical trial insurance is not intended as nor is a substitute for full and complete malpractice and other forms of liability insurance.
Clinical Trial Insurance. AgonOx shall obtain and shall maintain during the Term applicable clinical trial insurance, including coverage for Subject injury claims, as is necessary to cover all loss, destruction or damage resulting or occurring from or during the Phase I/II Clinical Trial, and shall name Phio as an additional insured with respect to such insurance. The cost of such insurance shall be deemed a Development Cost and included in the Budget. AgonOx shall cause its insurance policies to provide a waiver of subrogation in favor of Xxxx. The policy should be with at least a Standard & Poor’s A+ rated providing limits of no less than $10,000,000.00 per occurrence. AgonOx shall promptly furnish upon request certificate of insurance to Phio evidencing that the insurance required by this paragraph is in full force and effect. The certificates of insurance required hereunder shall contain a clause which provides that there shall be no reduction, cancellation or expiration of, or other material change to the policy without at least thirty (30) days’ prior written notice to Phio.
Clinical Trial Insurance. Effective at least [Redacted] prior to the launch of any human clinical trials sponsored by I-Mab under this Agreement (including, for clarity, any ongoing trials under the Initial Development Plan), I-Mab shall obtain a clinical trial insurance, with a minimum limit of [Redacted] in the aggregate, in force throughout the life of any such clinical trials, and such insurance shall be effected, maintained and documented to AbbVie in compliance with this Agreement and in compliance with any Applicable Law in the I-Mab Territory.
Clinical Trial Insurance. FFF shall procure and maintain, in full force and effect at all times during this Agreement clinical trial insurance coverage written by a responsible insurance carrier, Best Rated A, with limits of $10 million ($10,000,000) per occurrence and $10 million ($10,000,000) in the aggregate. The cost of such insurance will be shared equally by the Parties.
Clinical Trial Insurance. Sponsor declares the conclusion of liability insurance for damage caused by the Trial in according to provision of § 52 article 3, letter f) of law No. 378/2007 Coll., Pharmaceuticals, i.e. insurance to compensate damages in the event of the death of the Trial Participant or in the event of an injury to the health of Trial Participants as a direct result of their participation in the Trial. The insurance covers also the treatment in case of an injury. To that extent, such clinical trial insurance may also cover the relevant liability of Institution or Investigator. However, the Parties understand that the clinical trial insurance is not intended as nor is a substitute for full and complete malpractice and other forms of liability insurance. 12.8
Clinical Trial Insurance. Sponsor has effected insurance to compensate 11 ŠKODA NA ZDRAVÍ SUBJEKTU HODNOCENÍ, POJIŠTĚNÍ
Clinical Trial Insurance. Sponsor has effected sufficient insurance to compensate damages in the event of the death of the Trial Participant or in the event of an injury to the health of Trial Participants as a direct result of their participation in the Trial in accordance with the provisions of Section 52 (3) f) of Act No. 378/2007 Coll. The insurance covers also the treatment in case of an injury. To that extent, such clinical trial insurance may also cover the relevant liability of Provider or Investigator. However, the Parties understand that the clinical trial insurance is not intended as nor is a substitute for full and complete malpractice and other forms of provádění jakéhokoliv Studijního postupu vyžadovaného Protokolem, a to včetně peněžité náhrady vyvažující utrpení osob blízkých v případě usmrcení nebo zvlášť závažného ublížení na zdraví Subjektu hodnocení. Poskytovatel a/nebo Zkoušející jsou povinni neprodleně písemně informovat Zadavatele o jakémkoli nároku na základě onemocnění, úrazu nebo úmrtí Subjektů hodnocení, jehož skutečným nebo údajným důvodem je jejich účast v Klinickém hodnocení, umožnit Zadavateli vyřídit takový nárok (včetně jednání o mimosoudním narovnání) a plně s ním spolupracovat při vyřizování takového nároku. Poskytovatel poskytne Zadavateli dostatečnou dokumentaci k prověření a zpracování veškerých náhrad za škodu na zdraví Subjektu hodnocení, avšak s tím, že z veškeré dokumentace předložené Zadavateli budou odstraněny všechny identifikační znaky pacienta. Zadavatel je v případě nároku na základě onemocnění, úrazu nebo úmrtí způsobeného skutečně nebo údajně účastí daného Subjektu hodnocení v Klinickém hodnocení odpovědný za informování pojišťovny.
Clinical Trial Insurance. The Sponsor concluded in accordance with § 58 paragraph 2 letter n) Act No. 378/2007 Coll., on Medicines, as amended, before the start of the Trial, sufficient insurance for yourself and the Tester to cover damages in the event of death, injury or damage to the health of the Trial Subjects of the evaluation or damage caused to a person close to the Subject evaluations that were directly caused by the Evaluation Trial Subject's participation in the Trial, if such compensation is expressly provided for by applicable laws. The Sponsor undertakes to maintain the aforementioned insurance in force for the entire duration of the Trial. The insurance covers also the treatment in case of an injury. To that extent, such clinical trial insurance may also cover the relevant liability of Institution or Investigator. However, the Parties understand that the clinical trial insurance is not intended as nor is a substitute for full and complete malpractice and other forms of liability insurance. 9.4 9.3